Xencor | XNCR - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 59M 13M 2025-12
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Arrowhead Research USD 9.69M 637K 2025-12
AstraZeneca USD 73M 62M 2026-03
Biogen USD 37.9M 700K 2026-03
Cytokinetics USD 11.02M 448K 2026-03
GlaxoSmithKline GBP 22M 96M 2026-03
J&J USD 2.14 237M 2026-03
Karyopharm Therapeutics USD -0.15 0.11 2024-12
MacroGenics USD 1.53M 114K 2025-09
Merck USD 69M 27M 2025-12
Pfizer USD 115M 51M 2026-03
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Xencor USD 6.2M 338K 2025-12